Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO (molnupiravir) Read more
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York Read more
CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine Read more
Intravacc awarded US$14.6 Million NIH/NIAID contract to develop intranasal gonorrhea vaccine Read more
BioLink Life Sciences, Charak Foundation and KARE Biosciences Announce contract for developing a novel treatment of COVID pneumonia and prevention of long COVID Read more
Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine Read more